Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
04/14/2009 | US7517878 For example, 2-([3-tert-butyl-1-(2-methylphenyl)-1H-pyrazol-5-yl]amino)-6-methylnicotinic acid; compounds stimulate insulin secretion in the presence of glucose |
04/14/2009 | US7517877 5-substituted-alkylaminopyrazole derivatives as pesticides |
04/14/2009 | US7517875 Piperidine derivatives having CCR3 antagonism |
04/14/2009 | US7517594 Charge transfer layers; organic electronic devices |
04/14/2009 | US7517535 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags |
04/14/2009 | US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
04/14/2009 | CA2461432C Novel anthrapyridone compounds, water-base magenta ink compositions, and ink-jet recording process |
04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
04/14/2009 | CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
04/14/2009 | CA2396865C Farnesyl protein transferase inhibitors for treating breast cancer |
04/14/2009 | CA2359440C Phenylphenanthridines with pde-iv inhibiting activity |
04/14/2009 | CA2138533C Drugs that enhance synaptic responses mediated by ampa receptors |
04/09/2009 | WO2009045519A1 Modulators of muscarinic receptors |
04/09/2009 | WO2009045476A1 Pyrimidinedione derivatives |
04/09/2009 | WO2009045313A2 Oxypiperidine derivatives as histamine receptor antagonists |
04/09/2009 | WO2009044162A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use |
04/09/2009 | WO2009044160A1 Pyridine derivatives for the treatment of amyloid-related diseases |
04/09/2009 | WO2009043884A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors |
04/09/2009 | WO2009043797A2 Salts of a cgrp antagonist, method for producing the same and use thereof as drugs |
04/09/2009 | WO2009043780A1 Tetrazole-substituted aryl amide derivatives and uses thereof |
04/09/2009 | WO2009043747A2 N-heterocyclic biaryl carboxamides as ccr receptor antagonists |
04/09/2009 | WO2009043582A1 Nicotinamide n-oxide derivatives as vanilloid-1 receptor modulators |
04/09/2009 | WO2009021868A3 Novel piperazine amide derivatives |
04/09/2009 | WO2009020323A3 Process for preparing voriconazole |
04/09/2009 | WO2009019472A4 1, 2, 4 -triazole derivatives as serotonergic modulators |
04/09/2009 | WO2009013171A3 Heterocyclic antiviral compounds |
04/09/2009 | WO2008155666A3 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases |
04/09/2009 | WO2008152093A3 Diaminopyrimidines as modulators of the ep2 receptor |
04/09/2009 | WO2008148867A3 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
04/09/2009 | WO2008148710A3 Aryloxazole, aryloxadiazole and benzimidazole derivatives as modulators of somatostatins receptor activity |
04/09/2009 | WO2008074997A8 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
04/09/2009 | WO2008072257A3 Process for the preparation of indole derivatives |
04/09/2009 | WO2007141803A3 A process for the synthesis of (e) -2-[1 - (4 - methyl phenyl) -3-(1-pyrronyl)-1 - propenyl] pyridine (triprolidine) |
04/09/2009 | US20090093637 Synthesis of 1,3,4-Trisubstituted and 1,3,4,5-Tetrasubstituted Pyrazoles |
04/09/2009 | US20090093623 4,7-dichlororhodamine dyes |
04/09/2009 | US20090093524 Compounds and methods for modulating fxr |
04/09/2009 | US20090093523 Tetrazole-substituted aryl amide derivatives and uses thereof |
04/09/2009 | US20090093521 2, 5-Bis-Diamine [1,4] Benzoquinone-Derivatives |
04/09/2009 | US20090093518 Piperidinyl-substituted isoquinolone derivatives |
04/09/2009 | US20090093504 6-, 7-, or 8-Substituted Quinazolinone Derivatives and Compositions Comprising and Methods of Using the Same |
04/09/2009 | US20090093498 And beta-amyloid formation; Alzheimer's Disease; 2-amino-5-(4-fluoro-3-pyrimidin-5-ylphenyl)-5-(4-methoxy-3-methylphenyl)-3-methyl-3,5-dihydro-4H-imidazol-4-one |
04/09/2009 | US20090093497 Diacylglycerol Acyltransferase Inhibitors |
04/09/2009 | US20090093496 4-[4-[(R)-[1-[(cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl-1-piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine; mixture of rotamers; enriched in certain rotamers by reacting with benzoic, benzenesulfonic, nicotinic, glutaric acid; viricide, inflammation |
04/09/2009 | US20090093493 1-phenylalcoxy-2-beta-phenylethyl derivatives as p-glycoprotein (p-gp) inhibitors useful in drug resistance events |
04/09/2009 | US20090093480 Insecticidal pyrimidinyl aryl hyrdrazones |
04/09/2009 | US20090093479 Anti-cancer agents and uses thereof |
04/09/2009 | US20090093478 N-aroyl cyclic amines |
04/09/2009 | US20090093469 Phenylaminopropanol Derivatives and Methods of Their Use |
04/09/2009 | US20090093462 3-Arylamino pyridine derivatives |
04/09/2009 | US20090093451 IL-8 Receptor Antagonists |
04/09/2009 | US20090089939 Indole-derived styryl dye comprising an alkylene linker, a dye composition comprising this dye, and a process for lightening keratin materials using this dye |
04/09/2009 | DE102007047738A1 Imidazolderivate Imidazole derivatives |
04/09/2009 | CA2738980A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use |
04/09/2009 | CA2701214A1 Tetrazole-substituted aryl amide derivatives and uses thereof |
04/09/2009 | CA2701203A1 N-substituted oxindoline derivatives as calcium channel blockers |
04/09/2009 | CA2700963A1 Oxypiperidine derivatives and methods of use thereof |
04/09/2009 | CA2700928A1 Novel compounds |
04/09/2009 | CA2700724A1 Modulators of muscarinic receptors |
04/09/2009 | CA2700691A1 New biaryl derivatives |
04/08/2009 | EP2045251A1 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
04/08/2009 | EP2045250A1 Ring-substituted phenyl pyrrole aminoguanidine derivatives |
04/08/2009 | EP2045245A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
04/08/2009 | EP2045243A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
04/08/2009 | EP2045242A1 Heterocyclic compounds having inhibitory activity against HIV integrase |
04/08/2009 | EP2045238A1 Bridged cyanine compounds and optical recording materials containing the same |
04/08/2009 | EP2044957A1 Treatment agent for inflammatory bowel disease |
04/08/2009 | EP2044939A1 Therapeutic agent for liver fibrosis |
04/08/2009 | EP2044073A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
04/08/2009 | EP2044065A2 Compounds and compositions as hedgehog pathway modulators |
04/08/2009 | EP2044057A2 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
04/08/2009 | EP2044056A1 Pyrimidine derivatives as alk-5 inhibitors |
04/08/2009 | EP2044055A2 Amide compounds |
04/08/2009 | EP2044054A2 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity |
04/08/2009 | EP2044053A2 Urea compounds useful in the treatment of cancer |
04/08/2009 | EP2044052A1 Fungicide hydroximoyl-tetrazole derivatives |
04/08/2009 | EP2044051A1 Pyridine and pyrazine derivatives as mnk kinase inhibitors |
04/08/2009 | EP2044050A1 New pyridine analogues |
04/08/2009 | EP2044038A2 Novel piperazines, pharmaceutical compositions and methods of use thereof |
04/08/2009 | EP2044036A1 [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors |
04/08/2009 | EP2044031A1 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors |
04/08/2009 | EP2044019A1 3-oxoisoindoline-1-carboxamide derivatives as analgesic agents |
04/08/2009 | EP2044017A2 Substituted phenyl acetic acids as dp-2 antagonists |
04/08/2009 | EP2044016A2 4-heteroaryl-substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having effects on the opiod receptor system |
04/08/2009 | EP2044002A2 Process for making 3-substituted 2-amino-5-halobenzamides |
04/08/2009 | EP2043744A2 Chemical compounds |
04/08/2009 | EP2043441A1 Fungicide hydroximoyl-tetrazole derivatives |
04/08/2009 | EP1863933A4 Dimeric and trimeric nucleic acid dyes, and associated systems and methods |
04/08/2009 | EP1831198B1 Pyridine carboxamide derivatives for use as anticancer agents |
04/08/2009 | EP1831193B1 Imidazole derivatives |
04/08/2009 | EP1670470B1 Pyridine derivatives and use thereof as urotensin ii antagonists |
04/08/2009 | EP1606251B1 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
04/08/2009 | EP1551830B1 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibators |
04/08/2009 | EP1513811B1 Non-peptidic brs-3 agonists |
04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
04/08/2009 | EP1442026B1 Triazole derivatives as cyclooxygenase (cox) inhibitors |
04/08/2009 | EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists |
04/08/2009 | EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
04/08/2009 | EP0931063B3 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
04/08/2009 | CN101405285A Cyclic-alkylaminederivatives as inhibitors of the interaction between MDM2 and P53 |
04/08/2009 | CN101405284A Pyrimidine, quinazoline, pteridine and derivatives |